Inhibition of liver metastasis in mice by blocking hepatocyte lectins with arabinogalactan infusions and D-galactose
- PMID: 3818778
- PMCID: PMC12248396
- DOI: 10.1007/BF00389966
Inhibition of liver metastasis in mice by blocking hepatocyte lectins with arabinogalactan infusions and D-galactose
Abstract
According to our hypothesis, organ-specific lectins (e.g., the D-galactose-specific hepatic binding protein) play an important role in the organ location of metastatic malignant cells. The rapid clearance and uptake by the liver of tritiated alpha 1-acid-(asialo)glycoprotein from the circulation of Balb/c mice was markedly delayed after preinjection of D-galactose or arabinogalactan. The preinjection (1 h) and regular application (for 3 days after tumor cell inoculation in Balb/c mice) of the receptor blocking agents D-galactose and arabinogalactan prevented the settling of sarcoma L-1 tumor in the liver completely, but did not influence the settling in the lung. Other galactans, dextrans, and phosphate-buffered saline showed no effect. Therefore, when lectins were blocked with competitive-specific glycoconjugates, colonization was prevented.
References
-
- Ashwell G, Morell AG (1974) The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol 41:99–128 - PubMed
-
- Beuth J, Uhlenbruck G (1985) Leber-Lektine als Mediatoren der Metastasierung maligner Tumoren. Funkt Biol Med 5:269–275
-
- Beuth J, Oette K, Uhlenbruck G (1986) Liver lectins as receptors for tumor cells in metastasis. In: Van Driessche E, Bøg-Hansen TC (eds) Lectins, vol 5. Walter de Gruyter, Berlin, pp 229–237
-
- Fidler IJ (1985) Macrophages and Metastasis—A biological approach to cancer therapy. Cancer Res 45:4714–4726 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical